Document is current
Any future updates will be listed below
-
Authors
Gaur, Rajula
Mensah, Kofi A.
Stricker, Jason
Adams, Mary
Parton, Anastasia
Cedzik, Dorota
Connarn, Jamie
Thomas, Michael
Horan, Gerald
Schafer, Peter
Mair, Stuart
Palmisano, Maria
RamÃrez-Valle, Francisco
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb
- License Information
-
More Information
Article History
Received: 16 December 2021
Accepted: 13 June 2022
First Online: 18 August 2022
Declarations
:
: The clinical study protocol, informed consent document, and other study-related documents were reviewed and approved by the London-Riverside Research Ethics Committee (independent ethics committee) and the United Kingdom Medicines and Healthcare Products Regulatory Agency (MHRA). The study was conducted in compliance with the Declaration of Helsinki, International Council for Harmonisation Guideline for Good Clinical Practice, and applicable regional and country regulatory requirements.
: All study subjects provided written informed consent prior to the start of any study-specific procedures.
: RG, KM, JS, MA, SP, MT, GH, PS, MP, and FRV are employees of and shareholders in Bristol Myers Squibb. JC and DC are former employees of and shareholders in Bristol Myers Squibb. SM is an employee of and shareholder in Quotient Sciences.
